Hardik Desai Family Trust buys 8,643 Trident Texofab shares
- Hardik Desai Family Trust acquired 8,643 shares of Trident Texofab in the open market
- Stake increased from 6.89% to 6.95%, totaling 10,42,334 shares held
- Transaction disclosed under SEBI SAST Regulation 29(2) on August 26, 2026
- Total equity capital remains at ₹14,99,57,640 with no change in share count
*this image is generated using AI for illustrative purposes only.
Hardik Desai Family Trust has increased its stake in Trident Texofab by acquiring 8,643 equity shares in the open market on August 24, 2026. The transaction brings the trust’s total holding to 10,42,334 shares, representing a 6.95% stake in the company.
The acquisition was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing, dated August 26, 2026, confirms that the trust belongs to the promoter group. Hardik Jigishkumar Desai signed the disclosure as trustee.
What the Numbers Show
The trust’s stake rose from 6.89% (10,33,691 shares) before the transaction to 6.95% after the purchase. This represents a marginal increase of 0.06 percentage points in voting rights. No shares were encumbered or pledged in this specific transaction.
| Metric | Before Acquisition | After Acquisition |
|---|---|---|
| Shares Held | 10,33,691 | 10,42,334 |
| Stake Percentage | 6.89% | 6.95% |
| Encumbrances | Nil | Nil |
Trident Texofab’s total equity share capital remains unchanged at ₹14,99,57,640, comprising 1,49,95,764 equity shares of ₹10 each. The diluted share capital also remains at this level, indicating no outstanding convertible securities or warrants affecting the denominator for this calculation.
Historical Stock Returns for Trident Texofab
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.57% | +14.05% | -18.47% | -66.36% | -89.37% | -24.29% |
Does this incremental stake accumulation signal a potential move by the Hardik Desai Family Trust towards a higher threshold of control or a future open offer under SEBI takeover regulations?
How might this promoter group consolidation impact Trident Texofab's share price volatility and investor sentiment in the short term?
Are there any pending corporate actions, such as rights issues or bonus shares, that could dilute the trust's current 6.95% holding in the near future?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
